Similar articles for PMID: 11826197

Year	Number of Results
1995	2
1997	3
1998	3
1999	2
2000	1
2002	4
2003	8
2004	6
2005	2
2006	2
2007	1
2008	6
2009	4
2010	1
2011	3
2012	4
2013	8
2014	8
2015	9
2016	8
2017	5
2018	4
2020	1
2021	0

1

Risk factors for severe respiratory syncytial virus infection among Alaska native children.

Bulkow LR, Singleton RJ, Karron RA, Harrison LH; Alaska RSV Study Group. Bulkow LR, et al. Pediatrics. 2002 Feb;109(2):210-6. doi: 10.1542/peds.109.2.210. Pediatrics. 2002. PMID: 11826197

2

Bronchiolitis-associated hospitalizations among American Indian and Alaska Native children.

Lowther SA, Shay DK, Holman RC, Clarke MJ, Kaufman SF, Anderson LJ. Lowther SA, et al. Pediatr Infect Dis J. 2000 Jan;19(1):11-7. doi: 10.1097/00006454-200001000-00004. Pediatr Infect Dis J. 2000. PMID: 10643844

3

RSV-associated hospitalizations in Alaska Native infants.

Singleton R, Karron RA, Kruse DG, Harrison LH, DeSmet IJ, Davidson NM, Petersen KM. Singleton R, et al. Int J Circumpolar Health. 1998;57 Suppl 1:255-9. Int J Circumpolar Health. 1998. PMID: 10093285

4

Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population.

Holman RC, Curns AT, Cheek JE, Bresee JS, Singleton RJ, Carver K, Anderson LJ. Holman RC, et al. Pediatrics. 2004 Oct;114(4):e437-44. doi: 10.1542/peds.2004-0049. Pediatrics. 2004. PMID: 15466069

5

Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group.

Karron RA, Singleton RJ, Bulkow L, Parkinson A, Kruse D, DeSmet I, Indorf C, Petersen KM, Leombruno D, Hurlburt D, Santosham M, Harrison LH. Karron RA, et al. J Infect Dis. 1999 Jul;180(1):41-9. doi: 10.1086/314841. J Infect Dis. 1999. PMID: 10353859

6

Sequelae of severe respiratory syncytial virus infection in infancy and early childhood among Alaska Native children.

Singleton RJ, Redding GJ, Lewis TC, Martinez P, Bulkow L, Morray B, Peters H, Gove J, Jones C, Stamey D, Talkington DF, DeMain J, Bernert JT, Butler JC. Singleton RJ, et al. Pediatrics. 2003 Aug;112(2):285-90. doi: 10.1542/peds.112.2.285. Pediatrics. 2003. PMID: 12897275

7

Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants.

Singleton R, Dooley L, Bruden D, Raelson S, Butler JC. Singleton R, et al. Pediatr Infect Dis J. 2003 Jun;22(6):540-5. doi: 10.1097/01.inf.0000069768.34383.18. Pediatr Infect Dis J. 2003. PMID: 12799511

8

Respiratory syncytial virus infection in Navajo and White Mountain Apache children.

Bockova J, O'Brien KL, Oski J, Croll J, Reid R, Weatherholtz RC, Santosham M, Karron RA. Bockova J, et al. Pediatrics. 2002 Aug;110(2 Pt 1):e20. doi: 10.1542/peds.110.2.e20. Pediatrics. 2002. PMID: 12165619

9

Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia.

Weber MW, Milligan P, Hilton S, Lahai G, Whittle H, Mulholland EK, Greenwood BM. Weber MW, et al. Int J Epidemiol. 1999 Feb;28(1):157-62. doi: 10.1093/ije/28.1.157. Int J Epidemiol. 1999. PMID: 10195682

10

Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.

[No authors listed] [No authors listed] Pediatrics. 1998 Sep;102(3 Pt 1):531-7. Pediatrics. 1998. PMID: 9738173 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed